TAK241220C20000
- 0.00
- 0.000.00%
Takeda Pharmaceutical Newsroom
Hutchmed to Receive Milestone Payment for Takeda's Fruzaqla Launch in Japan
ADR Japanese stock rankings - overall buying dominance including Orient Land, Chicago at 38,230 yen, 190 yen higher than Osaka.
Japanese stocks of ADR (american depositary receipt) compared to the Tokyo Stock Exchange (calculated at 154.51 yen per dollar), such as Orion Land <4661>, Mitsubishi Corporation <8058>, komatsu <6301>, Disco <6146>, Tokyo Electron <8035>, SoftBank Group <9984>, Mizuho Financial Group <8411>, have risen, with buying pressure prevailing overall. The settlement price of the Chicago Nikkei 225 futures is 38,230 yen, which is 190 yen higher than during the Osaka day session. The US stock market has risen, with the dow inc gaining 461.88 dollars.
Regarding the launch of Fruquakra (Fulkinchynib) in japan for unresectable advanced or recurrent colorectal cancer.
Regarding the release of Furuzakura (Furukintinib) in japan for unresectable advanced or recurrent colorectal cancer that cannot be cured, on November 22, 2024, our company today announced the release of the orally administered tyrosine kinase inhibitor "Furuzakura Capsule 1mg/5mg" (generic name: Furukintinib), which has selectivity for vascular endothelial growth factor receptors (VEGFR) 1/2/3, for "unresectable advanced or recurrent colon and rectal cancer that worsened after cancer chemotherapy."
Regarding the release of the oral proteasome inhibitor "Ninlaro capsules 0.5 mg" in japan.
Regarding the launch of the oral proteasome inhibitor "Ninlaro Capsule 0.5 mg" in japan on November 22, 2024, the company announces that it has launched the oral proteasome inhibitor "Ninlaro Capsule 0.5 mg" (generic name: ixazomib citrate, hereafter referred to as "Ninlaro 0.5 mg") today. This is an additional formulation to the existing "Ninlaro Capsules 2.3 mg/3 mg/4 mg," which will be used in maintenance therapy for multiple myeloma.
The Nikkei average starts 0.53 yen higher, with companies like Furukawa Electric and MS&AD rising.
[Nikkei Average Stock Price・TOPIX (Table)] Nikkei Average; 38352.87; +0.53 TOPIX; 2700.14; +1.85 [Opening Overview] On the 21st, the Nikkei Average started trading up 0.53 yen at 38352.87 yen. The previous day, on the 20th, the U.S. stock market was mixed. The dow inc rose by 139.53 dollars to 43408.47 dollars, while the nasdaq closed down 21.33 points at 18966.14. Ukraine has provided British-made long-range missiles to Russia.
The New York market on the 20th was mixed.
[NYDow・Nasdaq・CME (Table)] NYDOW; 43,408.47; +139.53 Nasdaq; 18,966.14; -21.33 CME225; 38,280; -160 (TSE comparison) [NY Market Data] The NY market on the 20th was mixed. The Dow closed at 43,408.47, up 139.53 points, while the Nasdaq closed at 18,966.14, down 21.33 points. Ukraine launched a long-range British missile into Russian territory.
The US stock market is mixed, weighed down by geopolitical risks (on the 20th).
On the 20th, the 'Chicago Nikkei Average Futures (CME)' DEC24 O 38335 (dollar-denominated) H 38575 L 37885 C 38315 TSE -125 (evening +35) Vol 4292 DEC24 O 38325 (yen-denominated) H 38545 L 37850 C 38280 TSE -160 (evening +0) Vol 16836 'American Depositary Receipt Overview (ADR)' On the 20th in the ADR market, compared to the Tokyo Stock Exchange (1 dollar to 155.34 yen conversion),
Alloy Therapeutics Signs Collaboration And License Agreement With Takeda To Develop Takeda's Proprietary Induced Pluripotent Stem Cell Derived CAR-T Cell Platform And IPSC-Derived CAR-NK Platform
List of Cloud Breakout Stocks [Ichimoku Balance Table, List of Cloud Breakout Stocks]
○ List of stocks breaking through the clouds in the market Code Stock Name Closing Price Leading Span A Leading Span B Tokyo main board <1433> Bestera 948 947 871.5 <1820> Nishimatsu Construction 5150 5123468.5 <1860> Toda Corporation 1003959.7 5994.5 <1871> PS 10491034.7 5956 <1884> Nihon Doro 1696 1684.7 51597.5
TD Cowen Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating, Announces Target Price $16
Analysts Offer Insights on Healthcare Companies: Lineage Therap (LCTX), Veeva Systems (VEEV) and Takeda Pharmaceutical Company (TAK)
Chordia Research Memo (2): Spun out from takeda pharmaceuticals sp adr, focusing on the development of anticancer drugs.
■Company overview of Chordia Therapeutics <190A> 1. Company history The company is a bioventure established in October 2017 by six drug discovery researchers who spun out from takeda pharmaceuticals sp adr, where they were involved in the development of low molecular weight compound anticancer drugs. Four products were selected from the pipeline that was being developed during the takeda pharmaceuticals sp adr era, and a licensing agreement regarding exclusive research, development, manufacturing, and sales was signed with takeda pharmaceuticals sp adr in November of the same year.
Chordia---a biotech venture advancing the development of anticancer drugs that could become block inc.
Chordia Therapeutics <190A> is a biotech venture founded by drug discovery researchers who spun out from takeda pharmaceuticals sp adr <4502>, specializing in the development of low molecular weight anti-cancer drugs. The core business ranges from exploratory research to clinical research, and domestically, it conducts manufacturing and sales on its own through a partnership strategy, aiming for early monetization by licensing out overseas. It was listed on the Tokyo Stock Exchange Growth Market in June 2024.
Global Companies With at Least 50% U.S. Revenue Exposure as Trump Eyes Tariffs: BofA
US Manufacturing Index Rises To 43, Highest Since 2020
ADR Japanese stock rankings - Selling is dominant overall, including Japan Post Bank, with Chicago down 655 yen compared to Osaka at 38,015 yen.
In comparison to the Tokyo Stock Exchange (calculated at 154.32 yen per dollar), Japanese stocks of ADRs (american depositary receipt) such as Japan Post Bank <7182>, Tokyo Electron <8035>, Nidec <6594>, Advantest <6857>, Disco <6146>, Renesas <6723>, SoftBank Group <9984>, etc., have declined, leading to a general selling dominance. The Chicago Nikkei 225 futures settlement price is 38,015 yen, which is 655 yen lower than during the Osaka daytime. The us stock market continues to decline. The dow inc average is down by 305.87 dollars.
AC Immune's Active Immunotherapy Shows Antibody Responses In Early Parkinson's Patients
The PRIDE indicators include achieving Gold for four consecutive years in 2024, as well as receiving the first Rainbow certification.
On November 15, 2024, the PRIDE indicators will recognize for the fourth consecutive year the acquisition of PRIDE Gold, as well as the first-ever Rainbow certification, which evaluates corporate initiatives towards LGBTQ+ communities. This includes top recognition in the PRIDE indicators for efforts promoting collaboration across sectors. The recognition reflects Takeda's commitment to diversity, equity & inclusion based on our corporate philosophy.
Urgency, Debate Mark COP29 As Leaders Push For Carbon Market Rules, Worry About Trump
List of cloud breakout stocks (Part 1) [Ichimoku Kinko Hyo Cloud Breakout Stock List]
Above-the-clouds breakout stock list market Code Stock Name Closing Price Leading Span A Leading Span B Tokyo Stock Exchange main board <1808> Haseko 1882 1877.25 1754 <1861> Kumagai Gumi 3600 3583.75 3365 <1884> Nichidoro 1715 1708.25 1600 <1925> Daiwa House 4627 4564.5 158.5 <1942> Kandenko 2285 2196.25